Horrible Label! 150 and not 135 and only Secondary!

I’ll be contacting recruiters and networking this weekend. How could they do that to us?!!

 

Well they don't need 800 reps. Maybe for the 1st 12 months, but then shrink down.

 

NOW YOURE AN EVEN BIGGER BUYOUT TARGET!!!

 

You should. Of course they’ll spin it. But, they were really expecting a “Grand Slam” and this was a single... to use a sports analogy. Only up a few cents. Won’t hurt to network.

 

Amarins infrastructure is ramping up as it hit the grand slam, as you say, but i agree, it hit a single. Restructure coming after initial noisemaking

 

I won’t say it’s “Meh” but they definitely need Big Pharma’s help now.

 

You must be stupid. Great indication. Go sell insulin

 

I don’t see how this could have gone better. You think a doc is going to bat an eye on using vascepa in a 120 trig patient vs a 150? Or a 100 vs 150? Blockbuster, here we go.

 

Where do you get off saying it's only for secondary? Can you read? It clearly addresses more than just secondary prevention. Nice try.

 

You dont even work here. Go away, day trader.

 

It's primary and secondary prevention. $4 billion blockbuster drug!

 

You are spot on!!!!

$4 billion blockbuster drug made possible by Pfizer!!!

I'm a shareholder and nothing more. Hoping for another payday when the buyout is announced. Make me some money!!! Good luck to you.

 

Well, because health plans will only cover Vascepa if TGs are a minimum of 150mg/DL. That’s why!

 

Because no plan is currently covering under 500 trigs....

 

No insurance will ask for proof.... Do you know any insurance that asks for proof of high LDL before being prescribed statins? didn't think so.

Let say some do.. 150 is easily achievable. Just eat some hearty meal b4 bloodwork and bam! you got your 150. Yea yea, when asked if you fasted, just say sure! done.

 

Pfizer can negotiate for better managed care access. Pfizer is going to do a tremendous job at promoting vascepa for the remainder of the patent.

 

You're so sure this is gonna happen, huh? You're going to be one sad sack when it doesn't.

 

You’re so wrong. Pfizer won’t happen. It will be Gilead or Merck.

 

Gilead added a Vascepa arm to their NASH drug trial